"Bintai Kinden Corp Bhd is collaborating with Inst
Post# of 36537
"It said the collaboration was based on an existing partnership between the its subsidiary Bintai Healthcare Sdn Bhd (BHSB), Generex Biotechnology Corp (Generex) and NuGenerex Immuno-Oncology Inc to advance the commercialisation of Ii-Key-SARS-CoV-2 coronavirus (Covid-19) vaccine in Malaysia."
“After Generex has received the full Food and Drug Administration (FDA) approval on the vaccine and provides full documentation to BHSB, BHSB will commence the registration process to National Pharmaceutical Regulatory Agency (NPRA) of Malaysia for the vaccine,”
Questions
Did the "The Star" reporter and Surin Murugiah of the "theedgemarkets.com" do any actual investigation before they wrote these articles?
Has Bintai Kinden talked to its sub Bintai Healthcare lately?
Has Bintai Healthcare had contact with the Black Hole entity known as Generex lately?
Has NuGenerex submitted anything to the FDA, let alone actually having started trials?
After the Victoria Texas kerfuffle, until I see it in a 10Q/K… And even then…